| Patent | Date |
|---|
Anti-human P40 Protein Domain Antibody And Use Thereof
App 20220298235 - XIA; Yu ; et al. | 2022-09-22 |
Anti-ctla4-anti-pd-1 Bispecific Antibody And Uses Thereof
App 20220275089 - XIA; Yu ; et al. | 2022-09-01 |
Anti-pd-1 Antibody And Medical Use Thereof
App 20220267444 - WANG; Zhongmin ; et al. | 2022-08-25 |
Nucleic acid encoding PCSK9 antibody
Grant 11,402,383 - Li , et al. August 2, 2 | 2022-08-02 |
Therapeutic Combination Of Quinoline Derivative And Antibody
App 20220160700 - TIAN; Xin ; et al. | 2022-05-26 |
Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and uses
Grant 11,291,720 - Li , et al. April 5, 2 | 2022-04-05 |
Antibody Binding To Human Il-1 Beta, Preparation Method Therefor And Use Thereof
App 20220064282 - XIA; Yu ; et al. | 2022-03-03 |
Anti-pd-1/vegfa Bifunctional Antibody, Pharmaceutical Composition Thereof And Use Thereof
App 20210340239 - LI; Baiyong ; et al. | 2021-11-04 |
PDL-1 antibody, pharmaceutical composition thereof, and uses thereof
Grant 11,136,413 - Li , et al. October 5, 2 | 2021-10-05 |
Anti-PD-1 monoclonal antibody
Grant 11,104,734 - Xia , et al. August 31, 2 | 2021-08-31 |
ANTI-IL-1beta ANTIBODY AND PHARMACEUTICAL COMPOSITION THEREOF AND USE OF SAME
App 20210179706 - LI; Baiyong ; et al. | 2021-06-17 |
Monoclonal Antibody Of Nerve Growth Factor, And Encoding Gene And Use Thereof
App 20210155683 - Wang; Zhongmin Maxwell ; et al. | 2021-05-27 |
Anti-interleukin-17a Antibody, Pharmaceutical Composition Thereof And Use Thereof
App 20210122815 - LI; Baiyong ; et al. | 2021-04-29 |
Monoclonal antibody against PD-1 and application thereof
Grant 10,858,433 - Zhang , et al. December 8, 2 | 2020-12-08 |
Pcsk9 Antibody, And Pharmaceutical Composition And Use Thereof
App 20200319185 - LI; Baiyong ; et al. | 2020-10-08 |
Anti-ctla4 Monoclonal Antibody Or Its Antigen Binding Fragments, Pharmaceutical Compositions And Uses
App 20200206346 - LI; Baiyong ; et al. | 2020-07-02 |
PCSK9 antibody, and pharmaceutical composition and use thereof
Grant 10,670,604 - Li , et al. | 2020-06-02 |
Pdl-1 Antibody, Pharmaceutical Composition Thereof, And Uses Thereof
App 20200010570 - Li; Baiyong ; et al. | 2020-01-09 |
PDL-1 antibody, pharmaceutical composition thereof, and uses thereof
Grant 10,465,014 - Li , et al. No | 2019-11-05 |
Monoclonal Antibody Against Pd-1 And Application Thereof
App 20190330347 - ZHANG; Faming ; et al. | 2019-10-31 |
Anti-pd1 Monoclonal Antibody, Pharmaceutical Composition Thereof And Use Thereof
App 20190321466 - LI; Baiyong ; et al. | 2019-10-24 |
Anti-CTLA4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and uses
Grant 10,449,251 - Li , et al. Oc | 2019-10-22 |
Anti-ctla4 And Anti-pd-1 Bifunctional Antibody, Pharmaceutical Composition Thereof And Use Thereof
App 20190185569 - LI; Baiyong ; et al. | 2019-06-20 |
Anti-ctla4 Antibodies
App 20190177414 - LI; Baiyong ; et al. | 2019-06-13 |
Anti-PD-1 monoclonal antibody
App 20190040138 - Xia; Yu ; et al. | 2019-02-07 |
Pdl-1 Antibody, Pharmaceutical Composition Thereof, And Uses Thereof
App 20180305464 - Li; Baiyong ; et al. | 2018-10-25 |
Pcsk9 Antibody, And Pharmaceutical Composition And Use Thereof
App 20180024131 - LI; Baiyong ; et al. | 2018-01-25 |
An Anti-ctla4 Monoclonal Antibody Or Its Antigen Binding Fragments, Pharmaceutical Compositions And Uses
App 20170216433 - Li; Baiyong ; et al. | 2017-08-03 |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
Grant 6,878,522 - Li , et al. April 12, 2 | 2005-04-12 |
Methods for the identification of compounds useful for the treatment of disease states medicated by prostaglandin D2
App 20020022218 - Li, Baiyong ; et al. | 2002-02-21 |
| 